A breakthrough new drug that could save countless lives is in the pipeline following the discovery that a medication commonly used to combat river blindness can also kill the parasite that spreads malaria.
Ivermectin, a drug discovered in the Streptomyces avermitilis bacteria in 1975, has for more than 25 years been used to kill parasites including lice, mites, worms and nematodes by disrupting the fluid exchange through the insect’s cell membrane.
In March, scientists reported that recent vaccine trials in Burkina Faso using Ivermectin for conditions unrelated to malaria had also seen malarial transmission rates drop significantly.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
According to The Guardian, vaccination with the drug made “the blood of people who were repeatedly vaccinated lethal to mosquitoes”. Further research revealed that Ivermectin “can kill plasmodium falciparum, the malaria parasite carried by female mosquitoes”, the newspaper reports.
Experts now say that a new Ivermectin-based antimalarial drug could be released within two years.
Dr Simon Kariuki, head of the malaria branch at the Kenya Medical Research Institute (Kemri), said that human trials are being planned, adding: “We need more answers on Ivermectin. We need new malaria drugs as soon as possible as drug resistance is not something to ignore and we have to treat the situation as urgent.”
Although deaths from malaria have dropped by roughly 48% since 2000, recent figures show that malaria still killed 435,000 people in 2017, says The Telegraph.
And a study in August this year revealed that resistance to existing antimalarial drugs is increasing worldwide.
However, a paper published by the Yale School of Public Health earlier this year claimed that child malaria episodes could be reduced by up to 20% if populations living in high-risk areas were given Ivermectin.
-
What is Tony Blair's plan for Gaza?Today's Big Question Former PM has reportedly been putting together a post-war strategy 'for the past several months'
-
When does autumn begin?The Explainer The UK is experiencing a 'false autumn', as climate change shifts seasonal weather patterns
-
The rise of the performative maleTalking Point What the latest internet trope tells us about gender roles, dating and male illiteracy
-
Sloth fever shows no signs of slowing downThe explainer The vector-borne illness is expanding its range
-
A new subtype of diabetes was found and it may require different treatmentUnder the radar It is prevalent in Black Africans and Americans
-
How China is battling the chikungunya virusUnder The Radar Thousands of cases of the debilitating disease have been found in the country
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Babies born using 3 people's DNA lack hereditary diseaseUnder the Radar The method could eliminate mutations for future generations
-
Cytomegalovirus can cause permanent birth defectsThe Explainer The virus can show no symptoms in adults
-
Deadly fungus tied to a pharaoh's tomb may help fight cancerUnder the radar A once fearsome curse could be a blessing
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
